Helius Medical Technologies Inc [NASDAQ: HSDT] surged by $0.82 during the normal trading session on while it closed the day at $6.48.
Helius Medical Technologies Inc stock has also gained 16.13% of its value over the past 7 days. However, HSDT stock has declined by -19.88% in the 3 months of the year. Over the past six months meanwhile, it has lost -33.33% and lost -19.39% year-on date.
The market cap for HSDT stock reached $5.77 million, with 0.89 million shares outstanding and 0.85 million shares in the current float. Compared to the average trading volume of 310.70K shares, HSDT reached a trading volume of 5702059 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Helius Medical Technologies Inc [HSDT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HSDT shares is $19.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HSDT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Noble Capital Markets have made an estimate for Helius Medical Technologies Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 24, 2021.
The Average True Range (ATR) for Helius Medical Technologies Inc is set at 0.46, with the Price to Sales ratio for HSDT stock in the period of the last 12 months amounting to 9.01. The Price to Book ratio for the last quarter was 1.97, with the Price to Cash per share for the same quarter was set at 5.82.
HSDT stock trade performance evaluation
Helius Medical Technologies Inc [HSDT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 16.13. With this latest performance, HSDT shares gained by 11.72% in over the last four-week period, additionally sinking by -33.33% over the last 6 months – not to mention a drop of -49.14% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HSDT stock in for the last two-week period is set at 61.87, with the RSI for the last a single of trading hit 69.50, and the three-weeks RSI is set at 56.72 for Helius Medical Technologies Inc [HSDT]. The present Moving Average for the last 50 days of trading for this stock 6.00, while it was recorded at 5.84 for the last single week of trading, and 7.60 for the last 200 days.
Helius Medical Technologies Inc [HSDT]: An insightful look at the core fundamentals
Helius Medical Technologies Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.64 and a Current Ratio set at 3.88.
Helius Medical Technologies Inc [HSDT]: Institutional Ownership
The top three institutional holders of HSDT stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in HSDT stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in HSDT stock with ownership which is approximately 5.8386%.
